Acute demyelinating lesions with restricted diffusion in multiple sclerosis

Multiple Sclerosis Journal

Volumn 18, Issue 12, 2012, Pages 1745-1753

  Balashov, Konstantin E ^a   Lindzen, Eric ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

brain edema; demyelinating diseases; diffusion magnetic resonance imaging; magnetic resonance imaging; multiple sclerosis; relapsing remitting multiple sclerosis

Indexed keywords

ACUTE DEMYELINATING LESION WITH RESTRICTED DIFFUSION; ADULT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

EID: 84871541501     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512445407     Document Type: Review

References (33)

1. McFarland HF, Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol. 2007 ; 8: 913-919
2. Compston A, Coles A. Multiple sclerosis. Lancet. 2008 ; 372: 1502-1517
3. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology. 2000 ; 217: 331-345
4. Horsfield MA, Larsson HB, Jones DK, Gass A. Diffusion magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1998 ; 64: S80 - S84
5. Schaefer PW. Diffusion-weighted imaging as a problem-solving tool in the evaluation of patients with acute strokelike syndromes. Top Magn Reson Imaging. 2000 ; 11: 300-309
6. Castriota-Scanderbeg A, Sabatini U, Fasano F, et al. Diffusion of water in large demyelinating lesions: a follow-up study. Neuroradiology. 2002 ; 44: 764-767
7. Tievsky AL, Ptak T, Farkas J. Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions. AJNR Am J Neuroradiol. 1999 ; 20: 1491-1499
8. Albers GW. Diffusion-weighted MRI for evaluation of acute stroke. Neurology. 1998 ; 51: S47-49
9. Balashov KE, Aung LL, Dhib-Jalbut S, Keller IA. Acute multiple sclerosis lesion: conversion of restricted diffusion due to vasogenic edema. J Neuroimaging. 2011 ; 21: 202-204
10. Moritani T, Smoker WR, Sato Y, Numaguchi Y, Westesson PL. Diffusion-weighted imaging of acute excitotoxic brain injury. AJNR Am J Neuroradiol. 2005 ; 26: 216-228
11. Rosso C, Remy P, Creange A, Brugieres P, Cesaro P, Hosseini H. Diffusion-weighted MR imaging characteristics of an acute strokelike form of multiple sclerosis. AJNR Am J Neuroradiol. 2006 ; 27: 1006-1008
12. Rovira A, Pericot I, Alonso J, Rio J, Grive E, Montalban X. Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report. AJNR Am J Neuroradiol. 2002 ; 23: 989-994
13. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. 2005 ; 58: 840-846
14. Jacobs LD, Beck RW, Simon JH, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med. 2000 ; 343: 898-904
15. Geijer B, Sundgren PC, Lindgren A, Brockstedt S, Stahlberg F, Holtas S. The value of b required to avoid T2 shine-through from old lucunar infarcts in diffusion-weighted imaging. Neuroradiology. 2001 ; 43: 511-517
16. Purrmann J, Arendt G, Cleveland S, et al. Association of Crohn's disease and multiple sclerosis. Is there a common background?. J Clin Gastroenterol. 1992 ; 14: 43-46
17. Nielsen NM, Westergaard T, Frisch M, et al. Type 1 diabetes and multiple sclerosis: A Danish population-based cohort study. Arch Neurol. 2006 ; 63: 1001-1004
18. Okuda DT, Mowry EM, Beheshtian A, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 2009 ; 72: 800-805
19. Isaac C, Li DK, Genton M, et al. Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology. 1988 ; 38: 1511-1515
20. Zivadinov R, Leist TP. Clinical-magnetic resonance imaging correlations in multiple sclerosis. J Neuroimaging. 2005 ; 15: 10S - 21S
21. Proescholdt MA, Jacobson S, Tresser N, Oldfield EH, Merrill MJ. Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol. 2002 ; 61: 914-925
22. Sadeghi N, D'Haene N, Decaestecker C, et al. Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. AJNR Am J Neuroradiol. 2008 ; 29: 476-482
23. Miller DH, Rudge P, Johnson G, et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain. 1988 ; 111 (Pt 4). 927-939
24. Cotton F, Weiner HL, Jolesz FA, Guttmann CR. MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology. 2003 ; 60: 640-646
25. Rovaris M, Gass A, Bammer R, et al. Diffusion MRI in multiple sclerosis. Neurology. 2005 ; 65: 1526-1532
26. Roychowdhury S, Maldjian JA, Grossman RI. Multiple sclerosis: comparison of trace apparent diffusion coefficients with MR enhancement pattern of lesions. AJNR Am J Neuroradiol. 2000 ; 21: 869-874
27. Nusbaum AO, Lu D, Tang CY, Atlas SW. Quantitative diffusion measurements in focal multiple sclerosis lesions: correlations with appearance on TI-weighted MR images. AJR Am J Roentgenol. 2000 ; 175: 821-825
28. Richards TL, Alvord EC, He Y, et al. Experimental allergic encephalomyelitis in non-human primates: diffusion imaging of acute and chronic brain lesions. Mult Scler. 1995 ; 1: 109-117
29. Zecca C, Cereda C, Wetzel S, et al. Diffusion-weighted imaging in acute demyelinating myelopathy. Neuroradiology. 2011 ;:
30. Zacharia TT, Law M, Naidich TP, Leeds NE. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy. J Neuroimaging. 2008 ; 18: 411-417
31. Lindzen E, Jewells V, Bouldin T, Speer D, Royal W, Markovic-Plese S. Progressive tumefactive inflammatory central nervous system demyelinating disease in an acquired immunodeficiency syndrome patient treated with highly active antiretroviral therapy. J Neurovirol. 2008 ; 14: 569-573
32. Buckle C, Castillo M. Use of diffusion-weighted imaging to evaluate the initial response of progressive multifocal leukoencephalopathy to highly active antiretroviral therapy: early experience. AJNR Am J Neuroradiol. 2010 ; 31: 1031-1035
33. Lassmann H. Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J Neurol Sci. 2003 ; 206: 187-191